Search Results - "MACKINNON, Alison C"
-
1
Regulation of Transforming Growth Factor-β1-driven Lung Fibrosis by Galectin-3
Published in American journal of respiratory and critical care medicine (01-03-2012)“…Idiopathic pulmonary fibrosis (IPF) is a chronic dysregulated response to alveolar epithelial injury with differentiation of epithelial cells and fibroblasts…”
Get full text
Journal Article -
2
CD133+ Cancer Stem-like Cells in Small Cell Lung Cancer Are Highly Tumorigenic and Chemoresistant but Sensitive to a Novel Neuropeptide Antagonist
Published in Cancer research (Chicago, Ill.) (01-03-2014)“…Small cell lung cancer (SCLC) is a highly aggressive malignancy with poor survival rates, with initial responses nearly invariably followed by rapid recurrence…”
Get full text
Journal Article -
3
Regulation of Alternative Macrophage Activation by Galectin-3
Published in The Journal of immunology (1950) (15-02-2008)“…Alternative macrophage activation is implicated in diverse disease pathologies such as asthma, organ fibrosis, and granulomatous diseases, but the mechanisms…”
Get full text
Journal Article -
4
Galectin-3 Expression and Secretion Links Macrophages to the Promotion of Renal Fibrosis
Published in The American journal of pathology (01-02-2008)“…Macrophages have been proposed as a key cell type in the pathogenesis of renal fibrosis; however, the mechanism by which macrophages drive fibrosis is still…”
Get full text
Journal Article -
5
Selective Myeloid Depletion of Galectin-3 Offers Protection Against Acute and Chronic Lung Injury
Published in Frontiers in pharmacology (30-08-2021)“…Rationale: Galectin-3 (Gal-3) is an immune regulator and an important driver of fibrosis in chronic lung injury, however, its role in acute lung injury (ALI)…”
Get full text
Journal Article -
6
Resistance to anti-PD-1/anti-PD-L1: galectin-3 inhibition with GB1211 reverses galectin-3-induced blockade of pembrolizumab and atezolizumab binding to PD-1/PD-L1
Published in Frontiers in immunology (28-08-2023)“…Background Galectin-3 (Gal-3) is a β-galactoside-binding lectin that is highly expressed within the tumor microenvironment of aggressive cancers and has been…”
Get full text
Journal Article -
7
Galectin-3 Regulates Myofibroblast Activation and Hepatic Fibrosis
Published in Proceedings of the National Academy of Sciences - PNAS (28-03-2006)“…Central to fibrogenesis and the scarring of organs is the activation of fibroblasts into matrix-secreting myofibroblasts. We demonstrate that Galectin-3…”
Get full text
Journal Article -
8
Galectin-3 inhibitor GB0139 protects against acute lung injury by inhibiting neutrophil recruitment and activation
Published in Frontiers in pharmacology (08-08-2022)“…Rationale: Galectin-3 (Gal-3) drives fibrosis during chronic lung injury, however, its role in acute lung injury (ALI) remains unknown. Effective…”
Get full text
Journal Article -
9
Galectin-3 Reduces the Severity of Pneumococcal Pneumonia by Augmenting Neutrophil Function
Published in The American journal of pathology (01-02-2008)“…The Gram-positive Streptococcus pneumoniae is the leading cause of community-acquired pneumonia worldwide, resulting in high mortality. Our in vivo studies…”
Get full text
Journal Article -
10
Mammalian NOTCH-1 Activates β1 Integrins via the Small GTPase R-Ras
Published in The Journal of biological chemistry (28-09-2007)“…Notch is a central regulator of important cell fate decisions. Notch activation produces diverse cellular effects suggesting the presence of context-dependent…”
Get full text
Journal Article -
11
Proteinase activated receptor 1 mediated fibrosis in a mouse model of liver injury: a role for bone marrow derived macrophages
Published in PloS one (27-01-2014)“…Liver fibrosis results from the co-ordinated actions of myofibroblasts and macrophages, a proportion of which are of bone marrow origin. The functional effect…”
Get full text
Journal Article -
12
Intrapulmonary Autoantibodies to HSP72 Are Associated with Improved Outcomes in IPF
Published in Journal of immunology research (01-01-2019)“…Rationale. Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic interstitial lung disease, with high mortality. Currently, the aetiology and the…”
Get full text
Journal Article -
13
Target inhibition of galectin-3 by inhaled TD139 in patients with idiopathic pulmonary fibrosis
Published in The European respiratory journal (01-05-2021)“…Galectin (Gal)-3 is a profibrotic β-galactoside-binding lectin that plays a key role in the pathogenesis of idiopathic pulmonary fibrosis (IPF) and IPF…”
Get full text
Journal Article -
14
An Orally Active Galectin-3 Antagonist Inhibits Lung Adenocarcinoma Growth and Augments Response to PD-L1 Blockade
Published in Cancer research (Chicago, Ill.) (01-04-2019)“…A combination therapy approach is required to improve tumor immune infiltration and patient response to immune checkpoint inhibitors that target negative…”
Get full text
Journal Article -
15
CSF1 Restores Innate Immunity After Liver Injury in Mice and Serum Levels Indicate Outcomes of Patients With Acute Liver Failure
Published in Gastroenterology (New York, N.Y. 1943) (01-12-2015)“…Background & Aims Liver regeneration requires functional liver macrophages, which provide an immune barrier that is compromised after liver injury. The numbers…”
Get full text
Journal Article -
16
Discovery of the Selective and Orally Available Galectin‑1 Inhibitor GB1908 as a Potential Treatment for Lung Cancer
Published in Journal of medicinal chemistry (13-06-2024)“…We have previously described a new series of selective and orally available galectin-1 inhibitors resulting in the thiazole-containing glycomimetic GB1490…”
Get full text
Journal Article -
17
Cross-linking CD98 promotes integrin-like signaling and anchorage-independent growth
Published in Molecular biology of the cell (01-08-2002)“…CD98, an early marker of T-cell activation, is an important regulator of integrin-mediated adhesion events. Previous studies suggest that CD98 is coupled to…”
Get full text
Journal Article -
18
Effect of GB1107, a novel galectin-3 inhibitor on pro-fibrotic signalling in the liver
Published in European journal of pharmacology (01-12-2024)“…Galectin-3 (Gal-3) is a pro-fibrotic β-galactoside binding lectin highly expressed in fibrotic liver and implicated in hepatic fibrosis. GB1107 is a novel…”
Get full text
Journal Article -
19
An Inhaled Galectin-3 Inhibitor in COVID-19 Pneumonitis: A Phase Ib/IIa Randomized Controlled Clinical Trial (DEFINE)
Published in American journal of respiratory and critical care medicine (15-01-2023)“…High circulating galectin-3 is associated with poor outcomes in patients with coronavirus disease (COVID-19). We hypothesized that GB0139, a potent inhaled…”
Get full text
Journal Article -
20
Safety and pharmacokinetics of GB1211, an oral galectin-3 inhibitor: a single- and multiple-dose first-in-human study in healthy participants
Published in Cancer chemotherapy and pharmacology (01-03-2023)“…Purpose Galectin-3, a β-galactoside-binding lectin, plays a key role in several cellular pathways involved in chronic inflammation, heart disease and cancer…”
Get full text
Journal Article